Literature DB >> 14666710

Mimosine, a plant-derived amino acid induces apoptosis in human pancreatic cancer xenografts.

Attila Zalatnai1, Jozsef Bocsi.   

Abstract

BACKGROUND: Several studies have indicated that mimosine, a plant amino acid, is a potential inhibitor of the cell cycle giving rise to growth arrest in G1-phase. These results were mainly derived from in vitro investigations. To date only one paper is available about its applicability in xenografted lung tumor. This study revealed a tumor growth suppression and an increased apoptotic index. Our experiment was aimed at investigating the influence of mimosine in human pancreatic cancer.
MATERIALS AND METHODS: Subcutaneously growing human pancreatic cancer xenografts in immunosuppressed mice were treated with 30 mg/kg b.w. mimosine for 34 days and the apoptosis was assessed by flow cytometry.
RESULTS: Mimosine treatment resulted in a significant tumor growth suppression and the sub-G1 fraction was doubled (10.82 +/- 1.18% vs. 4.65 +/- 1.65 % in controls, p < 0.01).
CONCLUSION: This is the first evidence that mimosine exerts an apoptotic activity in xenotransplanted human pancreatic cancer and suppresses its growth.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14666710

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Mimosine-induced apoptosis in C6 glioma cells requires the release of mitochondria-derived reactive oxygen species and p38, JNK activation.

Authors:  Shanlou Qiao; Keiko Murakami; Qinghong Zhao; Baoling Wang; Hisao Seo; Hitoshi Yamashita; Xiaotao Li; Takashi Iwamoto; Masatoshi Ichihara; Masataka Yoshino
Journal:  Neurochem Res       Date:  2011-10-11       Impact factor: 3.996

2.  P-glycoprotein expression is induced in human pancreatic cancer xenografts during treatment with a cell cycle regulator, mimosine.

Authors:  Attila Zalatnai
Journal:  Pathol Oncol Res       Date:  2005-09-29       Impact factor: 3.201

3.  Anticancer activity of a novel methylated analogue of L-mimosine against an in vitro model of human malignant melanoma.

Authors:  Sotiris Kyriakou; Melina Mitsiogianni; Theodora Mantso; William Cheung; Stephen Todryk; Stephany Veuger; Aglaia Pappa; David Tetard; Mihalis I Panayiotidis
Journal:  Invest New Drugs       Date:  2019-06-26       Impact factor: 3.850

Review 4.  Natural Products and Synthetic Analogs as a Source of Antitumor Drugs.

Authors:  Javad Sharifi-Rad; Adem Ozleyen; Tugba Boyunegmez Tumer; Charles Oluwaseun Adetunji; Nasreddine El Omari; Abdelaali Balahbib; Yasaman Taheri; Abdelhakim Bouyahya; Miquel Martorell; Natália Martins; William C Cho
Journal:  Biomolecules       Date:  2019-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.